Obstructive Sleep Apnea Syndrome
Conditions
Brief summary
Study was planned to investigate the effect of pranayama on dyspnea, daytime sleepiness, cognitive function, quality of life, activities of daily living, functional exercise capacity, physical activity level, sleep quality, fatigue, musculoskeletal pain, depression and anxiety in OSAS.
Detailed description
Thirty-four OSAS patients meeting the inclusion criteria will be randomized into 2 groups as pranayama and control groups. The pranayama group will practice pranayama on their own for 8 weeks, 7 days a week, 3 times a day for 15 minutes. In addition, he will perform a single 15-minute session 3 days a week online under the supervision of a physiotherapist. The control group will not receive any intervention. Dyspnea sensation before and after the training Modified Medical Research Council dyspnea scale, daytime sleepiness Epworth Sleepiness Scale, cognitive function Montreal Cognitive Assessment Scale, quality of life Short Form-36, Turkish Adaptation of Nottingham Health Profile Questionnaire and Functional Outcomes of Sleep Questionnaire, activities of daily living London Chest Activities of Daily Living Scale, functional exercise capacity 30 seconds sit and stand test, physical activity level International Physical Activity Questionnaire-Short Form, sleep quality Pittsburgh Sleep Quality Index, fatigue status Fatigue Severity Scale, depression and anxiety Hospital Anxiety and Depression Scale, musculoskeletal system pain will be assessed with the Nordic Musculoskeletal Questionnaire.
Interventions
OTHERUjjayi pranayama, Nadi-Shodhana pranayama, Sukha pranayama
Ujjayi pranayama:It is a pranayamic application that is performed by slightly twisting the throat and breathing through the nose. Nadi shodhana pranayama is breathing alternately through the right and left nostrils.Sukha pranayama is inhaled through the nose for 5 seconds, then given through the nose for 5 seconds. Thus, 6 times of inspiration and expiration is done per minute.
Sponsors
Istanbul University - Cerrahpasa
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE
Intervention model description
Participants will be randomly divided into two groups as pranayama group and control group.
Eligibility
Sex/Gender
ALL
Age
20 Years to 60 Years
Healthy volunteers
No
Inclusion criteria
* Patients diagnosed with mild to moderate obstructive sleep apnea syndrome.
Exclusion criteria
* Using a mandibular advancement device * Regularly using hypnotic drugs * Have a metabolic disease (eg diabetes, hypothyroidism, obesity) * Have Hypertension * Have Malignancy * Have Epilepsy * Have Heart failure * Have COPD * Have asthma * Neurological, psychological, cooperative problems * Having a history of maxillofacial surgery
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Vital Capacity | 8 weeks | Vital capacity will be measured in liters, which is one of the respiratory functions. |
| Functional Exercise Capacity | 8 weeks | It will be evaluated by the 6-minute walking test. |
| Dyspnoea | 8 weeks | The resting dyspnea level will be evaluated according to the Modified Borg Scale. |
| fatigue | 8 weeks | Fatigue level will be assessed using the Fatigue Severity Scale (FSS). |
| Anxiety and Depression Status | 8 weeks | It will be evaluated with the Hospital Anxiety Depression Scale. |
| Physical Activity Level | 8 weeks | It will be evaluated with the International Physical Activity Questionnaire-Short form (IPAQ-S). |
| Cognitive Function | 8 weeks | Cognitive evaluation of the patients will be made with the Montreal Cognitive Assessment Scale (MOCA). |
| Daily Life Activities | 8 weeks | Daily life activities will be evaluated with the London Chest Daily Living Activities Scale. |
| Daytime Sleepiness | 8 weeks | Daytime sleepiness will be assessed with the Epworth Sleepiness Scale (ESS). |
| Sleep Quality | 8 weeks | Sleep quality will be evaluated with the Pittsburg Sleep Quality Index (PSQI). |
| Life Quality | 8 weeks | Quality of life will be evaluated with the SF-36 scale. |
| Inspiratory Muscle Strength | 8 weeks | Inspiratory muscle strength will be evaluated by measuring the maximum inspiratory pressure (MIP) in cmH2O. |
| Forced Vital Capacity | 8 weeks | Forced Vital Capacity will be measured in liters, which is one of the respiratory functions. |
| Expiratory Muscle Strength | 8 weeks | Expiratory muscle strength will be evaluated by measuring the maximum expiratory pressure (MIP) in cmH2O. |
Countries
Turkey (Türkiye)
Outcome results
None listed